Chronic Use of Hydrochlorothiazide and Risk of Skin Cancer in Caucasian Adults: A PharmLines Initiative Inception Cohort Study
Acta Dermato-Venereologica · 2023
DOI: 10.2340/actadv.v103.3933 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Acta Dermato-Venereologica, 2023. Verfasst von Marjolijn S Haisma und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Hauptthemen laut MEDLINE: Skin Neoplasms, Basal Cell Carcinoma, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Photosensitizing properties of hydrochlorothiazide may increase skin cancer risk. To date, study findings on the association between hydrochlorothiazide use and skin cancer risk are inconsistent, notably regarding confounding and dose-response. The aim of this study was to investigate the association between hydrochlorothiazide use and incidence of skin cancer in a cohort of unselected Caucasian adults, taking dosing into account. As part of the PharmLines Initiative, which links data from the Lifelines Cohort Study and prescription database IADB.nl, patients aged ≥ 40 years were included from Lifelines, a prospective population-based cohort study in the north of the Netherlands. Skin cancer incidence was compared between subjects starting hydrochlorothiazide treatment (n = 608), subjects starting treatment with other antihypertensives (n = 508), and non-antihypertensive long-term medication users (n = 1,710). Cox regression analyses were performed to obtain hazard ratios, adjusted for potential confounders. The risk of any skin cancer, keratinocyte carcinoma, basal cell carcinoma and squamous cell carcinoma was not significantly increased in general hydrochlorothiazide users. A clear association was observed between high cumulative hydrochlorothiazide use (≥ 5,000 defined daily dose; ≥ 125,000 mg) and the risk of any skin cancer (adjusted hazard ratio 5.32, 95% confidence interval (95% CI) 2.40–11.81), keratinocyte carcinoma (adjusted hazard ratio 7.31, 95% CI 3.12–17.13), basal cell carcinoma (adjusted hazard ratio 7.72, 95% CI 3.11–19.16) and squamous cell carcinoma (adjusted hazard ratio 19.63, 95% CI 3.12–123.56). These findings should lead to awareness with high use of hydrochlorothiazide in Caucasian adults.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
- Groningen Research Institute of Pharmacy, Unit PharmacoTherapy, -Epidemiology &-Economics, University of Groningen, Groningen, The Netherlands.
- Department of Pathology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
- Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
- Department of Dermatology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. e.racz@umcg.nl.
Zitieren
APA
Haisma, M. S., Greven, N., Logendran, M., Bos, J., van der Vegt, B., Horváth, B., De Vos, S., De Bock, G. H., Hak, E., & Rácz, E. (2023). Chronic Use of Hydrochlorothiazide and Risk of Skin Cancer in Caucasian Adults: A PharmLines Initiative Inception Cohort Study. Acta Dermato-Venereologica. https://doi.org/10.2340/actadv.v103.3933
Vancouver
Haisma MS, Greven N, Logendran M, Bos J, van der Vegt B, Horváth B, et al. Chronic Use of Hydrochlorothiazide and Risk of Skin Cancer in Caucasian Adults: A PharmLines Initiative Inception Cohort Study. Acta Dermato-Venereologica. 2023. doi:10.2340/actadv.v103.3933
BibTeX
@article{Haisma2023,
author = {Haisma, Marjolijn S and Greven, Nathalie and Logendran, Mathanhy and Bos, Jens and van der Vegt, Bert and Horváth, Barbara and De Vos, Stijn and De Bock, Geertruida H and Hak, Eelko and Rácz, Emőke},
title = {Chronic Use of Hydrochlorothiazide and Risk of Skin Cancer in Caucasian Adults: A PharmLines Initiative Inception Cohort Study},
journal = {Acta Dermato-Venereologica},
year = {2023},
doi = {10.2340/actadv.v103.3933}
}
EUVIMED